Centre to cap trade margins on non-scheduled cancer drugs to 30% of MRP
Average trade mark-up on these drugs now around 170%, reaching 700% in some cases; intervention to cut prices by up to 70% of MRP, resulting in cumulative annual savings of ₹2,500 crore for patients
· 10/8/2026, 4:39:39 PM· 2 min read
Average trade mark-up on these drugs now around 170%, reaching 700% in some cases; intervention to cut prices by up to 70% of MRP, resulting in cumulative annual savings of ₹2,500 crore for patients
Read original story →Related stories
breaking
SHAR Deputy Director urges educational institutions to set up Space Cells on campus
breaking
Andhra University extends deadline for special drive examination
breaking
51 booked for DJ sound violations during Ganesh festival in Hyderabad
breaking